Thomas Kosasa Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 1 hour ago
Thomas Kosasa has an estimated net worth of at least $13.2 million*, as of April 22, 2026. They own 15.8 million shares of ONMD stock. They have sold 0 shares of ONMD stock since 2021, for an estimated $-1.0 million.
Thomas Kosasa $ONMD SEC Form 4 Insider Trading
Thomas Kosasa has filed a total of 7 insider trades in $ONMD since 2021. Their most recent trade was a purchase of 595,238 shares, made on Feb 06, 2026. Their largest trade was a purchase of 1.2 million shares, made on Jun 20, 2025. We estimate that they now own 15.8 million shares of $ONMD, worth an estimated $14.3 million.
Insider Trading at $ONMD
There have been a total of 79 insider trades reported at $ONMD since 2021, with 5.7 million shares purchased and 126,322 shares sold. The most active insider traders in $ONMD stock have been Jeffrey Yu, Aaron Green, and Robert Lawrence Golden. The most recent trade was a purchase of 903,614 shares reported by Jeffrey Yu (Chief Medical Officer), made on Apr 01, 2026.
History of Insider Stock Trades by Thomas Kosasa
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ONMD
|
Purchase | 595,238 | Feb 06, 2026 | April 24, 2026, 8:40 a.m. |
|
ONMD
|
Purchase | 280,898 | Apr 23, 2026 | April 24, 2026, 8:40 a.m. |
|
ONMD
|
Purchase | 47,000 | Apr 21, 2025 | Nov. 26, 2025, 10:54 p.m. |
|
ONMD
|
Purchase | 55,000 | Jun 16, 2025 | Nov. 26, 2025, 10:54 p.m. |
|
ONMD
|
Purchase | 1.2 million | Jun 20, 2025 | Nov. 26, 2025, 10:54 p.m. |
|
ONMD
|
Purchase | 581,395 | Aug 29, 2025 | Nov. 26, 2025, 10:54 p.m. |
|
ONMD
|
Purchase | 6,000 | Sep 24, 2025 | Nov. 26, 2025, 10:54 p.m. |
$ONMD Executives and Stock Owners with Insider Trades
-
Jeffrey Yu, Chief Medical Officer
-
Aaron Green, Chief Executive Officer
-
Robert Lawrence Golden, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.